HomeSLRX • NASDAQ
add
Salarius Pharmaceuticals Inc
Previous close
$0.50
Day range
$0.48 - $0.52
Year range
$0.43 - $2.31
Market cap
2.15M USD
Avg Volume
213.26K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 8.08M | -54.14% |
Net income | -881.80K | 86.16% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -969.60K | 85.03% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 5.90M | -51.27% |
Total assets | 6.59M | -55.04% |
Total liabilities | 1.30M | -69.55% |
Total equity | 5.29M | — |
Shares outstanding | 4.31M | — |
Price to book | 0.37 | — |
Return on assets | -32.38% | — |
Return on capital | -40.05% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -881.80K | 86.16% |
Cash from operations | -1.51M | 67.94% |
Cash from investing | — | — |
Cash from financing | -169.45K | -16,945,000.00% |
Net change in cash | -1.68M | 64.35% |
Free cash flow | -1.25M | 68.89% |
About
Founded
2014
Headquarters
Website
Employees
2